These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35358375)

  • 1. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses.
    Chen H; Wu Z; Gong Z; Xia Y; Li J; Du L; Zhang Y; Gao X; Fan Z; Hu H; Qian Q; Ding Z; Guo S
    Adv Healthc Mater; 2022 Jul; 11(13):e2102784. PubMed ID: 35358375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Clinical Precision Chemotherapy by Patient-Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.
    Sun H; Sun L; Ke X; Liu L; Li C; Jin B; Wang P; Jiang Z; Zhao H; Yang Z; Sun Y; Liu J; Wang Y; Sun M; Pang M; Wang Y; Wu B; Zhao H; Sang X; Xing B; Yang H; Huang P; Mao Y
    Adv Sci (Weinh); 2024 Jan; 11(2):e2304460. PubMed ID: 37973557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling cancer metastasis using acoustically bio-printed patient-derived 3D tumor microtissues.
    Chen H; Du L; Li J; Wu Z; Gong Z; Xia Y; Fan Z; Qian Q; Ding Z; Hu H; Guo S
    J Mater Chem B; 2022 Mar; 10(11):1843-1852. PubMed ID: 35224593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation.
    Dai R; Chen W; Chen Y; Jin J; Zhang S; Zhang C; Liu J
    Biofabrication; 2024 Jun; 16(3):. PubMed ID: 38810618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converging bioprinting and organoids to better recapitulate the tumor microenvironment.
    Wang X; Luo Y; Ma Y; Wang P; Yao R
    Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
    Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
    Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.
    Hao M; Cao Z; Wang Z; Xin J; Kong B; Xu J; Zhang L; Chen P
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3515-3525. PubMed ID: 35696669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acoustic droplet printing of functional tumor microenvironments.
    Chen K; Jiang E; Wei X; Xia Y; Wu Z; Gong Z; Shang Z; Guo S
    Lab Chip; 2021 Apr; 21(8):1604-1612. PubMed ID: 33683268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Organoid-Based Preclinical Model of Human Gastric Cancer.
    Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprinting of Human Liver-Derived Epithelial Organoids for Toxicity Studies.
    Bouwmeester MC; Bernal PN; Oosterhoff LA; van Wolferen ME; Lehmann V; Vermaas M; Buchholz MB; Peiffer QC; Malda J; van der Laan LJW; Kramer NI; Schneeberger K; Levato R; Spee B
    Macromol Biosci; 2021 Dec; 21(12):e2100327. PubMed ID: 34559943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.
    Mollica PA; Booth-Creech EN; Reid JA; Zamponi M; Sullivan SM; Palmer XL; Sachs PC; Bruno RD
    Acta Biomater; 2019 Sep; 95():201-213. PubMed ID: 31233891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells.
    Kijima T; Nakagawa H; Shimonosono M; Chandramouleeswaran PM; Hara T; Sahu V; Kasagi Y; Kikuchi O; Tanaka K; Giroux V; Muir AB; Whelan KA; Ohashi S; Naganuma S; Klein-Szanto AJ; Shinden Y; Sasaki K; Omoto I; Kita Y; Muto M; Bass AJ; Diehl JA; Ginsberg GG; Doki Y; Mori M; Uchikado Y; Arigami T; Avadhani NG; Basu D; Rustgi AK; Natsugoe S
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):73-91. PubMed ID: 30510992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging organoid models: leaping forward in cancer research.
    Fan H; Demirci U; Chen P
    J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer Patient-Derived 2D and 3D Models Efficiently Recapitulate Inter- and Intratumoral Heterogeneity.
    Zhao Y; Zhang B; Ma Y; Zhao F; Chen J; Wang B; Jin H; Zhou F; Guan J; Zhao Q; Wang H; Liu Q; Zhao F; Wang X
    Adv Sci (Weinh); 2022 Aug; 9(22):e2201539. PubMed ID: 35652270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation.
    Choi YM; Lee H; Ann M; Song M; Rheey J; Jang J
    Biofabrication; 2023 Jun; 15(3):. PubMed ID: 37236168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug screening at single-organoid resolution via bioprinting and interferometry.
    Tebon PJ; Wang B; Markowitz AL; Davarifar A; Tsai BL; Krawczuk P; Gonzalez AE; Sartini S; Murray GF; Nguyen HTL; Tavanaie N; Nguyen TL; Boutros PC; Teitell MA; Soragni A
    Nat Commun; 2023 Jun; 14(1):3168. PubMed ID: 37280220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.